Stocktoria

Oncology Institute, Inc. TOI

Nasdaq · XNAS · stock · Services-Offices & Clinics of Doctors of Medicine · website · IPO 2020-03-13
Chart by TradingView
4/9
Piotroski F — financial health
-5.27
Altman Z″ — distress risk · distress
Dividend payout · no dividend

Financials & ratios (annual, from 10-K)

MetricFY2025FY2024FY2023FY2022FY2021
Financials
Revenue$502.7M$393.4M$324.2M$252.5M$203.0M
Operating income-$36.1M-$60.1M-$77.0M-$82.0M-$45.9M
Net income-$60.6M-$64.7M-$83.1M$152,000-$10.9M
Operating cash flow-$24.6M-$26.5M-$36.3M-$61.8M-$32.7M
Free cash flow-$27.8M-$30.3M-$40.9M-$67.3M-$35.5M
Total assets$164.7M$172.7M$209.2M$261.7M$203.4M
Total liabilities$180.4M$169.1M$152.2M$138.5M$99.3M
Shareholders' equity-$15.7M$3.6M$57.0M$123.2M$104.2M
Ratios
Operating margin-7.2%-15.3%-23.8%-32.5%-22.6%
Net margin-12.1%-16.4%-25.6%0.1%-5.4%
FCF margin-5.5%-7.7%-12.6%-26.6%-17.5%
Return on assets-36.8%-37.4%-39.7%0.1%-5.4%
Return on equity385.5%-1801.7%-145.7%0.1%-10.5%
Debt / equity-4.92×25.95×1.52×0.65×0.00×
Current ratio1.592.154.124.395.17
Revenue growth27.8%21.3%28.4%24.4%8.3%

Notable holders (13F)

InvestorSharesValue
RENAISSANCE TECHNOLOGIES LLC902,809$2.8M

Why these scores methodology →

Piotroski F-score: 4/9

  • Positive return on assets
  • Positive operating cash flow
  • Rising ROA
  • Cash flow exceeds net income
  • Lower long-term debt
  • Rising current ratio
  • No share dilution
  • Rising gross margin
  • Rising asset turnover

Altman Z″: -5.27 (distress)

  • Working capital / assets 0.254
  • Retained earnings / assets -1.648
  • EBIT / assets -0.219
  • Equity / liabilities -0.087

Sector peers

GOOG · MSFT · META · BABA · DIS · HCA · all Services →

Source: SEC EDGAR filings · CIK 0001799191 · as of 2025-12-31. Figures are facts from filings plus Stocktoria's own computed scores — not investment advice.